β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt

Journal of Molecular and Cellular Cardiology

Volumn 72, Issue , 2014, Pages 39-51

  Grisanti, Laurel A ^a   Talarico, Jennifer A ^b   Carter, Rhonda L ^a   Yu, Justine E ^a   Repas, Ashley A ^a   Radcliffe, Scott W ^b   Tang, Hoang ai ^b   Makarewich, Catherine A ^a   Houser, Steven R ^a   Tilley, Douglas G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apoptosis; Cardiomyocyte; Epidermal growth factor receptor; Adrenergic receptor

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA ADRENERGIC RECEPTOR; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; EGFR PROTEIN, MOUSE; QUINAZOLINE DERIVATIVE; TYRPHOSTIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL MEMBRANE; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; GENE EXPRESSION; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CAT; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PRIMARY CELL CULTURE; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASE 3; CATS; GENE EXPRESSION REGULATION; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 84901200242     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.02.009     Document Type: Article

References (86)

1. Tilley D.G. G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function. Circ Res 2011, 109:217-230.
2. Houser S.R., Margulies K.B., Murphy A.M., Spinale F.G., Francis G.S., Prabhu S.D., et al. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 2012, 111:131-150.
3. Zhang X., Szeto C., Gao E., Tang M., Jin J., Fu Q., et al. Cardiotoxic and cardioprotective features of chronic beta-adrenergic signaling. Circ Res 2013, 112:498-509.
4. Noma T., Lemaire A., Naga Prasad S.V., Barki-Harrington L., Tilley D.G., Chen J., et al. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 2007, 117:2445-2458.
5. Kubon C., Mistry N.B., Grundvold I., Halvorsen S., Kjeldsen S.E., Westheim A.S. The role of beta-blockers in the treatment of chronic heart failure. Trends Pharmacol Sci 2011, 32:206-212.
6. Violin J.D., Soergel D.G., Boerrigter G., Burnett J.C., Lark M.W. GPCR biased ligands as novel heart failure therapeutics. Trends Cardiovasc Med 2013, 23(7):242-249.
7. Kim I.M., Tilley D.G., Chen J., Salazar N.C., Whalen E.J., Violin J.D., et al. Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci U S A 2008, 105:14555-14560.
8. Chen H., Ma N., Xia J., Liu J., Xu Z. Beta2-adrenergic receptor-induced transactivation of epidermal growth factor receptor and platelet-derived growth factor receptor via Src kinase promotes rat cardiomyocyte survival. Cell Biol Int 2012, 36:237-244.
9. Wang Y., Pennock S., Chen X., Wang Z. Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol 2002, 22:7279-7290.
10. She Q.B., Solit D.B., Ye Q., O'Reilly K.E., Lobo J., Rosen N. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer cell 2005, 8:287-297.
11. Ramljak D., Coticchia C.M., Nishanian T.G., Saji M., Ringel M.D., Conzen S.D., et al. Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells. Exp Cell Res 2003, 287:397-410.
12. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005, 288:H971-H976.
13. Forster K., Kuno A., Solenkova N., Felix S.B., Krieg T. The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol 2007, 293:H1604-H1608.
14. Krieg T., Cui L., Qin Q., Cohen M.V., Downey J.M. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol 2004, 36:435-443.
15. Methner C., Donat U., Felix S.B., Krieg T. Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8. Acta Physiol 2009, 197:265-271.
16. Tilley D.G., Kim I.M., Patel P.A., Violin J.D., Rockman H.A. Beta-arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J Biol Chem 2009, 284:20375-20386.
17. Maudsley S., Pierce K.L., Zamah A.M., Miller W.E., Ahn S., Daaka Y., et al. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 2000, 275:9572-9580.
18. Makarewich C.A., Correll R.N., Gao H., Zhang H., Yang B., Berretta R.M., et al. A caveolae-targeted L-type Ca(2)+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility. Circ Res 2012, 110:669-674.
19. Silver L.H., Hemwall E.L., Marino T.A., Houser S.R. Isolation and morphology of calcium-tolerant feline ventricular myocytes. Am J Physiol 1983, 245:H891-H896.
20. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995, 267:1782-1788.
21. Norris R.P., Freudzon M., Nikolaev V.O., Jaffe L.A. Epidermal growth factor receptor kinase activity is required for gap junction closure and for part of the decrease in ovarian follicle cGMP in response to LH. Reproduction 2010, 140:655-662.
22. Kulkarni G.V., McCulloch C.A. Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts. J Cell Sci 1994, 107(Pt 5):1169-1179.
23. Braun F., Bertin-Ciftci J., Gallouet A.S., Millour J., Juin P. Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-x(L) inhibition. PLoS One 2011, 6:e23577.
24. Kuzman J.A., Gerdes A.M., Kobayashi S., Liang Q. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. J Mol Cell Cardiol 2005, 39:841-844.
25. Zhu H., McElwee-Witmer S., Perrone M., Clark K.L., Zilberstein A. Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis. Cell Death Differ 2000, 7:773-784.
26. Wu C.F., Bishopric N.H., Pratt R.E. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 1997, 272:14860-14866.
27. Datta S.R., Ranger A.M., Lin M.Z., Sturgill J.F., Ma Y.C., Cowan C.W., et al. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev Cell 2002, 3:631-643.
28. Gardai S.J., Hildeman D.A., Frankel S.K., Whitlock B.B., Frasch S.C., Borregaard N., et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004, 279:21085-21095.
29. Kim A.H., Khursigara G., Sun X., Franke T.F., Chao M.V. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 2001, 21:893-901.
30. Yeh J.H., Hsu S.C., Han S.H., Lai M.Z. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J Exp Med 1998, 188:1795-1802.
31. Soker T., Godecke A. Expression of the murine Nr4a1 gene is controlled by three distinct genomic loci. Gene 2013, 512:517-520.
32. Wajant H., Moosmayer D., Wuest T., Bartke T., Gerlach E., Schonherr U., et al. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene 2001, 20:4101-4106.
33. Di Pietro R., Zauli G. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J Cell Physiol 2004, 201:331-340.
34. Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2000, 2:241-243.
35. Liao X., Wang X., Gu Y., Chen Q., Chen L.Y. Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Life Sci 2005, 77:160-174.
36. McCole D.F., Truong A., Bunz M., Barrett K.E. Consequences of direct versus indirect activation of epidermal growth factor receptor in intestinal epithelial cells are dictated by protein-tyrosine phosphatase 1B. J Biol Chem 2007, 282:13303-13315.
37. Kehat I., Molkentin J.D. Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci 2010, 1188:96-102.
38. Baines C.P., Molkentin J.D. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005, 38:47-62.
39. Tucka J., Bennett M., Littlewood T. Cell death and survival signalling in the cardiovascular system. Front Biosci 2012, 17:248-261.
40. Yoon S., Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006, 24:21-44.
41. Murphy L.O., Blenis J. MAPK signal specificity: the right place at the right time. Trends Biochem Sci 2006, 31:268-275.
42. Kondoh K., Torii S., Nishida E. Control of MAP kinase signaling to the nucleus. Chromosoma 2005, 114:86-91.
43. Mebratu Y., Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?. Cell Cycle 2009, 8:1168-1175.
44. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 2012, 66:105-143.
45. von Zastrow M., Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol 2007, 19:436-445.
46. Miaczynska M., Pelkmans L., Zerial M. Not just a sink: endosomes in control of signal transduction. Curr Opin Cell Biol 2004, 16:400-406.
47. Sadowski L., Pilecka I., Miaczynska M. Signaling from endosomes: location makes a difference. Exp Cell Res 2009, 315:1601-1609.
48. Haugh J.M., Huang A.C., Wiley H.S., Wells A., Lauffenburger D.A. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem 1999, 274:34350-34360.
49. Burke P., Schooler K., Wiley H.S. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell 2001, 12:1897-1910.
50. Sorkin A. Internalization of the epidermal growth factor receptor: role in signalling. Biochem Soc Trans 2001, 29:480-484.
51. Stern K.A., Place T.L., Lill N.L. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate. Biochem J 2008, 410:585-594.
52. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992, 360:689-692.
53. Fazioli F., Minichiello L., Matoska V., Castagnino P., Miki T., Wong W.T., et al. Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J 1993, 12:3799-3808.
54. Margolis B., Li N., Koch A., Mohammadi M., Hurwitz D.R., Zilberstein A., et al. The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. EMBO J 1990, 9:4375-4380.
55. Anderson D., Koch C.A., Grey L., Ellis C., Moran M.F., Pawson T. Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 1990, 250:979-982.
56. Thien C.B., Langdon W.Y. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene. Oncogene 1997, 14:2239-2249.
57. Levkowitz G., Waterman H., Ettenberg S.A., Katz M., Tsygankov A.Y., Alroy I., et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 1999, 4:1029-1040.
58. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev 1998, 12:3663-3674.
59. Lill N.L., Douillard P., Awwad R.A., Ota S., Lupher M.L., Miyake S., et al. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. J Biol Chem 2000, 275:367-377.
60. Muthuswamy S.K., Gilman M., Brugge J.S. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol Cell Biol 1999, 19:6845-6857.
61. Sousa L.P., Lax I., Shen H., Ferguson S.M., De Camilli P., Schlessinger J. Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane. Proc Natl Acad Sci U S A 2012, 109:4419-4424.
62. Brankatschk B., Wichert S.P., Johnson S.D., Schaad O., Rossner M.J., Gruenberg J. Regulation of the EGF transcriptional response by endocytic sorting. Sci Signal 2012, 5:ra21.
63. Vieira A.V., Lamaze C., Schmid S.L. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996, 274:2086-2089.
64. Madshus I.H., Stang E. Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking. J Cell Sci 2009, 122:3433-3439.
65. Wakshull E.M., Wharton W. Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis. Proc Natl Acad Sci U S A 1985, 82:8513-8517.
66. Boivin B., Lavoie C., Vaniotis G., Baragli A., Villeneuve L.R., Ethier N., et al. Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res 2006, 71:69-78.
67. Vaniotis G., Del Duca D., Trieu P., Rohlicek C.V., Hebert T.E., Allen B.G. Nuclear beta-adrenergic receptors modulate gene expression in adult rat heart. Cell Signal 2011, 23:89-98.
68. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001, 3:802-808.
69. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., et al. Apoptosis in the failing human heart. N Engl J Med 1997, 336:1131-1141.
70. Saraste A., Pulkki K., Kallajoki M., Heikkila P., Laine P., Mattila S., et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 1999, 29:380-386.
71. Zaugg M., Xu W., Lucchinetti E., Shafiq S.A., Jamali N.Z., Siddiqui M.A. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000, 102:344-350.
72. Dalal S., Foster C.R., Das B.C., Singh M., Singh K. Beta-adrenergic receptor stimulation induces endoplasmic reticulum stress in adult cardiac myocytes: role in apoptosis. Mol Cell Biochem 2012, 364:59-70.
73. Wang W., Zhang H., Gao H., Kubo H., Berretta R.M., Chen X., et al. {beta}1-Adrenergic receptor activation induces mouse cardiac myocyte death through both L-type calcium channel-dependent and -independent pathways. Am J Physiol Heart Circ Physiol 2010, 299:H322-H331.
74. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998, 98:1329-1334.
75. Murray D.R., Mummidi S., Valente A.J., Yoshida T., Somanna N.K., Delafontaine P., et al. Beta2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo. J Mol Cell Cardiol 2012, 52:206-218.
76. Salie R., Moolman J.A., Lochner A. The role of beta-adrenergic receptors in the cardioprotective effects of beta-preconditioning (betaPC). Cardiovasc Drugs Ther 2011, 25:31-46.
77. Salie R., Moolman J.A., Lochner A. The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation. Basic Res Cardiol 2012, 107:281.
78. Schneider P., Olson D., Tardivel A., Browning B., Lugovskoy A., Gong D., et al. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem 2003, 278:5444-5454.
79. Spierings D.C., de Vries E.G., Vellenga E., van den Heuvel F.A., Koornstra J.J., Wesseling J., et al. Tissue distribution of the death ligand TRAIL and its receptors. J Histochem Cytochem 2004, 52:821-831.
80. Osmancik P., Teringova E., Tousek P., Paulu P., Widimsky P. Prognostic value of TNF-related apoptosis inducing ligand (TRAIL) in acute coronary syndrome patients. PLoS One 2013, 8:e53860.
81. Secchiero P., Corallini F., Beltrami A.P., Ceconi C., Bonasia V., Di Chiara A., et al. An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. Atherosclerosis 2010, 210:274-277.
82. Secchiero P., Corallini F., Ceconi C., Parrinello G., Volpato S., Ferrari R., et al. Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction. PLoS One 2009, 4:e4442.
83. Volpato S., Ferrucci L., Secchiero P., Corallini F., Zuliani G., Fellin R., et al. Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. Atherosclerosis 2011, 215:452-458.
84. Niessner A., Hohensinner P.J., Rychli K., Neuhold S., Zorn G., Richter B., et al. Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J 2009, 30:789-796.
85. Lula J.F., Rocha M.O., Nunes Mdo C., Ribeiro A.L., Teixeira M.M., Bahia M.T., et al. Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction. Eur J Heart Fail 2009, 11:825-831.
86. Kim J., Eckhart A.D., Eguchi S., Koch W.J. Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J Biol Chem 2002, 277:32116-32123.